Top Clinical Trials companies in India by Return on Equity (ROE)

This ranking features the top 13 Clinical Trials companies in India ranked by Return on Equity (ROE), averaging a Return on Equity (ROE) of -18.65%, for February 02, 2025.
#
Name
Return on Equity (ROE)
Reported Date
Stock Price
Change
Price (30 days) Country
1
1,348.13%
March 31, 2024 USD 0.14 3.84%

India

2
44.97%
March 31, 2024 USD 1.29 2.70%

India

3
23.56%
March 31, 2024 USD 6.91 -0.24%

India

4
19.34%
March 31, 2024 USD 32.88 -0.93%

India

5
13.43%
March 31, 2024 USD 9.20 2.64%

India

6
12.83%
March 31, 2024 USD 9.86 2.71%

India

7
11.98%
March 31, 2024 USD 8.61 -1.79%

India

8
11.66%
March 31, 2024 USD 20.71 -0.50%

India

9
2.96%
March 31, 2024 USD 0.59 -0.38%

India

10
1.42%
March 31, 2024 USD 11.23 1.68%

India

11
-19.13%
March 31, 2024 USD 16.75 0.23%

India

12
-38.91%
March 31, 2024 USD 1.48 10.54%

India

13
-307.91%
March 31, 2024 USD 1.84 1.24%

India

Frequently Asked Questions
  • Which Clinical Trials company in India has the highest Return on Equity (ROE) ?

    The Clinical Trials company in India with the highest Return on Equity (ROE) is TAKE Solutions Limited (NSE: TAKE.NS) at 1,348.13%.

  • Which Clinical Trials company in India has the lowest Return on Equity (ROE) ?

    The Clinical Trials company in India with the lowest Return on Equity (ROE) is Sun Pharma Advanced Research Company Limited (NSE: SPARC.NS) at -307.91%.

SV Wall Street